Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2006 | 12-2005 | |
| Sales | 2,986 | 0 | 0 |
| Gross Profit | 2,986 | N/A | N/A |
| Operating Expenses | 9,578 | 0 | 0 |
| Operating Income | -6,592 | N/A | N/A |
| Pre-tax Income | -6,592 | 0 | 0 |
| Net Income Continuous | -6,592 | N/A | N/A |
| Net Income | $-6,592 | $N/A | $N/A |
| EPS Basic Total Ops | -2.60 | N/A | N/A |
| EPS Basic Continuous Ops | -2.59 | N/A | N/A |
| EPS Diluted Total Ops | -2.60 | N/A | N/A |
| EPS Diluted Continuous Ops | -2.59 | N/A | N/A |
| EBITDA(a) | $-6,413 | $N/A | $N/A |